PODD Insulet Corporation
XNAS 148.99 DelayedStock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
- 52-Week Range
- $126.40 – $354.88
- YTD
- -47.34%
- IV Rank (30D)
- 70.17
- Straddle Price
- $18.20
- P/C Vol Ratio
- 0.77
- Market Cap
- $10.3B
- Open
- $147.87
- Day Range
- $145.00 – $149.69
- Volume
- 803,141
- Prev Close
- $148.12
A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.
- DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
- Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
- DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
- P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
- Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
- Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
- Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
- Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
| 10-yr Treasury (rf) | 5.12% |
| Beta vs SPY | 0.92 |
| Cost of Equity (CAPM) | 9.71% (VRP-adj) |
| WACC | 9.36% |
| Volatility Risk Premium | +24.8pp (IV − HV30) |
| Effective Tax Rate | 24.1% |
| Rev. Growth (YoY, DCF input) | +13.5% |
| DCF Horizon | 10 years explicit + fade |
| Forward Tilt (NTM/TTM) | ×1.10 (applied to P/E, EV/EBITDA, P/S) |
| Free Cash Flow (TTM) | $0.3B |
| Return on Equity (TTM) | 26.4% |
| Book / Price | 13.6% |
| Gross Margin (TTM) | 71.1% |
| FCF Margin (TTM) | 9.3% |
| Debt / Equity | 0.65 |
| Quality Score | 3/6 — normal (10y DCF) |
| Market-Implied Growth | +18.9% (reverse-DCF on current price) |
| SMA 50 | $140.45 (Market Anchor value) |
| SMA 20 / Bollinger Mid | $136.79 |
| Bollinger Width / SMA20 | 9.7% (drives anchor stability) |
| Net Debt | $0.4B |
| Market Cap | $10B |
| Method | Implied Price | Weight | Detail |
|---|---|---|---|
| DCF | $107.80 | 19% | |
| DDM (Gordon) | n/a | 0% | |
| Peer P/E | $183.15 | 9% | median 31.2× · 6 peers |
| Peer EV/EBITDA | $187.88 | 9% | median 20.2× · 6 peers |
| Peer P/B | $211.80 | 2% | median 10.5× · 8 peers |
| Peer P/S | $456.65 | 6% | median 9.6× · 8 peers |
| Market Anchor (SMA50) | $140.45 | 38% | stability 100% (BB-width) |
| Options Expected (B-L 30d) | $148.29 | 18% | 19 strikes · skew +0.41 |
- Industry (SIC)
- SURGICAL & MEDICAL INSTRUMENTS & APPARATUS (3841) · industry map
- Exchange
- XNAS
- Market Cap
- $10.3B
- Employees
- 5,400
- List Date
- 2007-05-15
- CIK
- 0001145197
- Next Earnings
- 2026-11-04 (Pre-Market)
- EPS Forecast
- $1.59 (8 est.)
- Headquarters
- Acton, MA
- Homepage
- https://www.insulet.com
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
| Month | '21 | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|---|
| Jan | 6.18% | -10.05% | 0.33% | -8.72% | 8.38% | -9.58% | -2.24% |
| Feb | -1.76% | 6.70% | -4.88% | -16.07% | -2.38% | -3.90% | -3.71% |
| Mar | -3.46% | 2.13% | 12.91% | 1.27% | -3.68% | -14.51% | -0.89% |
| Apr | 11.48% | -14.35% | -0.25% | 2.28% | -4.14% | -16.86% | -3.64% |
| May | -4.40% | -13.63% | -13.99% | 4.06% | 29.88% | -17.20% | -2.55% |
| Jun | 3.80% | 5.09% | 5.82% | 11.24% | -3.33% | 2.78% | 4.23% |
| Jul | 0.39% | 9.42% | -2.36% | -0.92% | -3.86% | 3.61% | 1.05% |
| Aug | 6.86% | 3.98% | -29.24% | 2.80% | 19.29% | -12.40% | -1.45% |
| Sep | -5.25% | -11.61% | -17.01% | 12.61% | -10.49% | -12.07% | -7.30% |
| Oct | 8.65% | 11.09% | -19.67% | -1.29% | 2.30% | 13.93%* | 2.50% |
| Nov | -6.56% | 12.52% | 37.30% | 13.23% | 2.64% | -- | 11.83% |
| Dec | -6.13% | -4.42% | 12.90% | -2.03% | -8.55% | -- | -1.65% |
| Total | 7.91% | -8.44% | -30.15% | 15.37% | 20.90% | -52.21% | -7.77% |
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
Momentum Oscillators
Volume & Volatility
Data Summary
LLM Stock Analysis Report
Executive Summary Overall Assessment: BEARISH (Confidence Level: 7/10)
Key Drivers:
- Recent news headlines highlighting securities fraud lawsuits and regulatory issues
- Bearish momentum signals from MACD and RSI indicators
- Volatility regime indicating low volatility, but options market pricing a potential $15.00 move
Primary Risks:
- Regulatory issues and litigation concerns
- Potential for further stock price declines if negative news persists
Investment Thesis: The stock has been under pressure due to ongoing regulatory issues and securities fraud lawsuits. The technical indicators are signaling bearish momentum, while the options market is pricing a potential $15.00 move. The recent news headlines have negatively impacted the sentiment, making it challenging for the stock to recover in the short term.
Recent News Sentiment Impact: The negative news headlines have created a bearish sentiment, which has contributed to the decline in the stock price.
Technical Analysis
Trend Direction: BEARISH (Short-term), NEUTRAL (Medium-term)
Support/Resistance Levels:
- Lower Bollinger Band: $132.80
- Middle Bollinger Band: $156.81
Momentum Signals: RSI: 40.26 (neutral) MACD: Bearish signal (-4.29 / Signal: -2.14 / Histogram: -2.15)
Volume Analysis: Volume SMA 20: 1552314.30 On-Balance Volume (OBV): -3275048.16 Volume Rate of Change: -55.95%
News & Sentiment Analysis
Recent Headlines Summary: The recent news headlines highlight securities fraud lawsuits and regulatory issues, which have negatively impacted the sentiment.
Sentiment Assessment: Aggregate News Sentiment: NEGATIVE
Catalyst Identification: No imminent catalysts identified in the near term.
Market Narrative: The negative news headlines have created a bearish market narrative, which has contributed to the decline in the stock price.
Risk & Volatility Assessment
Beta Interpretation: Risk relative to market (beta 0.28), indicating low risk.
Volatility Regime: Low volatility, with options market pricing a potential $15.00 move by expiration.
Options Market Signals: IV Rank: 20.8% (Low) Put/Call Volume Ratio: 0.51 Market Expectation: Options market pricing $15.00 move by expiration
Downside Protection: Support levels and risk management considerations are crucial to mitigate further losses.
Market Context & Positioning
Sector Performance: Insulet Corporation is a healthcare technology company, which is relatively stable in this sector.
Institutional Activity: Volume patterns suggesting institutional interest are low.
Correlation Analysis: The stock has a weak correlation with the market (R-squared interpretation), indicating limited market influence.
Relative Valuation: The stock is trading within its historical range, but the negative news headlines have created a bearish sentiment.
Key Levels & Action Items
Critical Price Levels:
- Lower Bollinger Band: $132.80
- Middle Bollinger Band: $156.81
Breakout/Breakdown Levels:
- Critical levels to monitor for potential reversals or continued declines.
Time-Sensitive Catalysts: No imminent catalysts identified in the near term.
Risk Management: Stop-loss levels and position sizing considerations are crucial to mitigate further losses.
Conclusion The stock has been under pressure due to ongoing regulatory issues and securities fraud lawsuits. The technical indicators signal bearish momentum, while the options market prices a potential $15.00 move. The recent news headlines have created a bearish sentiment, making it challenging for the stock to recover in the short term. Further losses are possible if negative news persists.
| Earnings Date | Timing | Expected Move | Actual Move | Ratio | Outcome |
|---|---|---|---|---|---|
| 2021-02-23 | Pre-Market | 11.07% | 1.65% | 0.15x | Within |
| 2021-05-06 | Pre-Market | 11.37% | 4.27% | 0.38x | Within |
| 2021-08-05 | Pre-Market | 3.70% | 0.45% | 0.12x | Within |
| 2021-11-04 | Pre-Market | 16.19% | 3.32% | 0.21x | Within |
| 2022-02-23 | Pre-Market | 12.14% | 1.59% | 0.13x | Within |
| 2022-05-05 | Pre-Market | 5.12% | 8.14% | 1.59x | Exceeded |
| 2022-08-04 | Pre-Market | 10.81% | 1.86% | 0.17x | Within |
| 2022-11-03 | Pre-Market | 8.94% | 2.43% | 0.27x | Within |
| 2023-02-23 | Pre-Market | 9.31% | 3.41% | 0.37x | Within |
| 2023-05-04 | Pre-Market | 7.69% | 0.39% | 0.05x | Within |
| 2023-08-08 | Pre-Market | 8.78% | 8.63% | 0.98x | Within |
| 2023-11-02 | Pre-Market | 15.50% | 1.98% | 0.13x | Within |
| 2024-02-22 | Pre-Market | 13.64% | 2.42% | 0.18x | Within |
| 2024-05-09 | Pre-Market | 12.53% | 1.12% | 0.09x | Within |
| 2024-08-08 | After-Close | 11.80% | 8.81% | 0.75x | Within |
| 2024-11-07 | After-Close | 12.25% | 9.40% | 0.77x | Within |
| 2025-05-08 | Pre-Market | 8.19% | 2.77% | 0.34x | Within |
| 2025-08-07 | Pre-Market | 9.95% | 9.47% | 0.95x | Within |
| 2025-11-06 | Pre-Market | 11.99% | 2.85% | 0.24x | Within |
| 2026-02-18 | Pre-Market | 8.89% | 4.76% | 0.54x | Within |
| 2026-05-06 | Pre-Market | 11.22% | 9.70% | 0.86x | Within |
| 2026-08-05 | Pre-Market | 12.89% | 20.12% | 1.56x | Exceeded |
Earnings calendar: this week’s reports with expected vs actual moves →
PODD Options Activity & IV Rank
PODD IV rank history, 52-week IV rank and IV percentile →
Volatility Metrics
Options Flow
ATM Options Pricing
Chain Summary
Each spread is ranked by a composite score built in three stages. Full documentation →
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Estimated net dealer gamma is at the 29th percentile of this name's own daily history, within its typical range. This describes current positioning; it is not a forecast or a trading signal.
Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.
Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.
Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.
This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Enter a ticker to render the implied volatility surface.
Enter a ticker to render the implied volatility smile.
Risk Metrics
Analysis Details
Data Points: 251
Period: 252 trading days
Low volatility - stock moves less than market
| Investor | Value | Share of their portfolio | Rank | Q/Q shares | Source |
|---|---|---|---|---|---|
| Millennium Management Hedge fund Izzy Englander | $131.8M | #254 of 3716 | +189.8% | 13F | |
| Citadel Hedge fund Ken Griffin | $121.3M | #342 of 6285 | +419.3% | 13F | |
| Renaissance Technologies Hedge fund Jim Simons | $30.8M | #525 of 3138 | -52.6% | 13F | |
| Bridgewater Associates Hedge fund Ray Dalio | $23.8M | #174 of 997 | +342.6% | 13F | |
| Rockefeller Capital Management Family office Rockefeller family | $697K | #1907 of 4729 | -5.3% | 13F |
Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions
PODD Institutional Ownership (13F)
Latest filings — 2026-09-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Citadel Advisors LLC Custodian | $5.30M | 24.57% | 2026-06-30 |
| 2 | Jane Street Group, LLC Custodian | $4.23M | 19.63% | 2026-06-30 |
| 3 | Squarepoint Ops LLC | $2.07M | 9.60% | 2026-06-30 |
| 4 | Wolverine Trading, LLC Custodian | $1.99M | 9.22% | 2025-09-30 |
| 5 | Susquehanna International Group, LLP Custodian | $1.78M | 8.26% | 2026-06-30 |
| 6 | Cubist Systematic Strategies, LLC | $1.17M | 5.44% | 2025-09-30 |
| 7 | Walleye Capital LLC | $1.08M | 5.01% | 2026-06-30 |
| 8 | TUDOR INVESTMENT CORP ET AL | $959.17K | 4.45% | 2026-06-30 |
| 9 | Point72 Asset Management, L.P. | $959.17K | 4.45% | 2026-06-30 |
| 10 | UBS Group AG Custodian | $728.97K | 3.38% | 2026-06-30 |
| 11 | CSS LLC/IL | $685.12K | 3.18% | 2026-06-30 |
| 12 | Walleye Trading LLC | $365.40K | 1.69% | 2026-06-30 |
| 13 | Twin Tree Management, LP | $228.38K | 1.06% | 2026-06-30 |
| 14 | CAPTRUST FINANCIAL ADVISORS | $15.22K | 0.07% | 2026-06-30 |
| # | Filer | Notional Value | % of Total | Period |
|---|---|---|---|---|
| 1 | Wolverine Trading, LLC Custodian | $8.57M | 32.30% | 2025-09-30 |
| 2 | Citadel Advisors LLC Custodian | $4.60M | 17.32% | 2026-06-30 |
| 3 | D. E. Shaw & Co., Inc. Custodian | $3.32M | 12.50% | 2026-06-30 |
| 4 | Susquehanna International Group, LLP Custodian | $3.14M | 11.82% | 2026-06-30 |
| 5 | Jane Street Group, LLC Custodian | $3.04M | 11.47% | 2026-06-30 |
| 6 | WOLVERINE ASSET MANAGEMENT LLC | $1.66M | 6.25% | 2026-06-30 |
| 7 | Point72 Asset Management, L.P. | $1.20M | 4.53% | 2026-06-30 |
| 8 | Cubist Systematic Strategies, LLC | $401.35K | 1.51% | 2025-09-30 |
| 9 | TUDOR INVESTMENT CORP ET AL | $319.73K | 1.20% | 2026-06-30 |
| 10 | Walleye Capital LLC | $213.15K | 0.80% | 2026-06-30 |
| 11 | Walleye Trading LLC | $76.12K | 0.29% | 2026-06-30 |
PODD Insider Trading (Form 4)
Latest: 2026-10-05| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-10-05 | Flavia Pease | EVP & CFO | Tax (F) | −1,882 | $130.79 | -$246.1K | EDGAR |
| 2026-10-02 | Robert Luther Huffines | Director | Award (A) | +178 | $130.47 | $23.2K | EDGAR |
| 2026-10-02 | Jonathan Jay Mazelsky | Director | Award (A) | +141 | $130.47 | $18.4K | EDGAR |
| 2026-08-24 | Ashley McEvoy | President and CEO | Buy (P) | +1,100 | $147.47 | $162.2K | EDGAR |
| 2026-08-04 | Lisa Blair Davis | SVP, Chief HR Officer | Tax (F) | −244 | $165.35 | -$40.3K | EDGAR |
| 2026-07-07 | Robert Luther Huffines | Director | Award (A) | +151 | $152.25 | $23.0K | EDGAR |
| 2026-07-02 | Jonathan Jay Mazelsky | Director | Award (A) | +1,355 | — | EDGAR | |
| 2026-07-02 | Robert Luther Huffines | Director | Award (A) | +144 | $159.79 | $23.0K | EDGAR |
| 2026-06-04 | Luciana Borio | Director | Sell (S) | −418 | $143.27 | -$59.9K | EDGAR |
| 2026-06-04 | Timothy C. Stonesifer | Director | Buy (P) | +2,790 | $143.51 | $400.4K | EDGAR |
| 2026-06-03 | Elizabeth H Weatherman | Director | Buy (P) | +3,450 | $144.20 | $497.5K | EDGAR |
| 2026-05-21 | Luciana Borio | Director | Award (A) | +1,660 | — | EDGAR | |
| 2026-05-21 | Wayne A.I. Frederick | Director | Award (A) | +1,660 | — | EDGAR | |
| 2026-05-21 | Jessica Hopfield | Director | Award (A) | +1,660 | — | EDGAR | |
| 2026-05-21 | Robert Luther Huffines | Director | Award (A) | +1,660 | — | EDGAR |
PODD Insider Holdings
22 insiders · @ $149.01| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | James Hollingshead | Former President and CEO | 61,247 | $9.13M | $1.01M | 14 | 2025-04-30 |
| 2 | Timothy J Scannell | Director | 33,024 | $4.92M | -$2.97M | 16 | 2026-05-21 |
| 3 | Jessica Hopfield | Director | 29,355 | $4.37M | -$3.18M | 16 | 2026-05-21 |
| 4 | John W. Kapples | SVP and General Counsel | 27,514 | $4.10M | -$1.68M | 24 | 2026-03-03 |
| 5 | Eric Benjamin | EVP and COO | 23,868 | $3.56M | -$10.15M | 35 | 2026-03-03 |
| 6 | Ashley McEvoy | President and CEO | 23,735 | $3.54M | $1.19M | 5 | 2026-08-24 |
| 7 | Michael R Minogue | Director | 19,921 | $2.97M | $1.51M | 16 | 2026-05-21 |
| 8 | Flavia Pease | EVP & CFO | 17,357 | $2.59M | $0 | 6 | 2026-10-05 |
| 9 | Ana Maria Chadwick | EVP, CFO & Treasurer | 14,263 | $2.13M | $20.6K | 4 | 2025-05-05 |
| 10 | Mark N Field | SVP & Chief Technology Officer | 13,411 | $2.00M | -$1.29M | 12 | 2025-03-04 |
PODD Board & Officers
As of SEC filings through Oct 5, 2026Directors 10
- Timothy J Scannell · since Aug 12, 2014
- Jessica Hopfield · since Jul 27, 2015
- Michael R Minogue · since Aug 10, 2017
- Wayne A.I. Frederick · since Oct 20, 2020
- Luciana Borio · since Oct 15, 2021
- Elizabeth H Weatherman · since Feb 4, 2022
- Timothy C. Stonesifer · since Jan 18, 2024
- Ashley McEvoy · since Apr 28, 2025
- Robert Luther Huffines · since Oct 31, 2025
- Jonathan Jay Mazelsky · since Jul 1, 2026
Officers 11
- Ashley McEvoy · President and CEO · since Apr 28, 2025
- Ana Maria Chadwick · EVP, CFO & Treasurer · since Apr 22, 2024
- Flavia Pease · EVP & CFO · listed since Oct 2025
- Eric Benjamin · EVP and COO · listed since Feb 2026
- Dan Manea · SVP, Chief HR Officer · since May 28, 2020
- Lisa Blair Davis · SVP, Chief HR Officer · since Jul 8, 2025
- John W. Kapples · SVP and General Counsel · listed since Feb 2022
- Michael Panos · EVP and CCO · since Mar 30, 2026
- Lauren Budden · Group VP, CAO and Controller · listed since Mar 2022
- Laetitia Cousin · SVP, Reg, Quality & Compliance · since Mar 23, 2023
- Prem Singh · SVP, Global Operations · since Mar 23, 2023
Changes in the last 10 years (58)
| Jul 1, 2026 | Jonathan Jay Mazelsky became a director |
| Mar 30, 2026 | Michael Panos became EVP and CCO |
| Feb 17, 2026 | Eric Benjamin listed as EVP and COO (previously EVP, Cpxo) in SEC filings |
| Oct 31, 2025 | Robert Luther Huffines became a director |
| Oct 2, 2025 | Flavia Pease first listed as EVP & CFO in an SEC filing |
| Sep 11, 2025 | The company announced the departure of Flavia Pease from the board in an SEC filing |
| Jul 8, 2025 | Lisa Blair Davis became SVP, Chief HR Officer |
| Apr 30, 2025 | James Hollingshead reported in an SEC filing no longer being a director |
| Apr 30, 2025 | James Hollingshead reported in an SEC filing no longer being President and CEO |
| Apr 28, 2025 | Ashley McEvoy became a director |
| Apr 28, 2025 | Ashley McEvoy became President and CEO |
| Mar 14, 2025 | The company announced the departure of Mark N Field as SVP & Chief Technology Officer in an SEC filing |
| Feb 28, 2025 | Eric Benjamin listed as EVP, Cpxo (previously EVP, Cpxpo) in SEC filings |
| Apr 22, 2024 | Ana Maria Chadwick became EVP, CFO & Treasurer |
| Feb 29, 2024 | Eric Benjamin listed as EVP, Cpxpo (previously EVP, Innovation and Strategy) in SEC filings |
| Jan 18, 2024 | Timothy C. Stonesifer became a director |
| Jan 18, 2024 | The company announced the departure of Corinne H Nevinny from the board in an SEC filing |
| Jan 18, 2024 | Flavia Pease became a director |
| Jan 17, 2024 | The company announced the departure of Shacey Petrovic from the board in an SEC filing |
| Sep 29, 2023 | The company announced the departure of Wayde D. McMillan as EVP, CFO in an SEC filing |
| Jul 1, 2023 | Mark N Field became SVP & Chief Technology Officer |
| May 24, 2023 | Shacey Petrovic no longer listed as Advisor in SEC filings |
| Mar 23, 2023 | Prem Singh became SVP, Global Operations |
| Mar 23, 2023 | Laetitia Cousin became SVP, Reg, Quality & Compliance |
| Feb 13, 2023 | Shacey Petrovic first listed as Advisor in an SEC filing |
| Feb 13, 2023 | Michael P Spears listed as Advisor (previously SVP, RA and Compliance) in SEC filings |
| Feb 13, 2023 | Eric Benjamin listed as EVP, Innovation and Strategy (previously SVP, Innovation and Strategy) in SEC filings |
| Feb 13, 2023 | Charles Alpuche listed as Advisor (previously EVP & Chief Operating Officer) in SEC filings |
| Jun 2, 2022 | James Hollingshead first listed as President and CEO in an SEC filing |
| May 4, 2022 | The company announced the departure of Shacey Petrovic as President and CEO in an SEC filing |
| Mar 2, 2022 | Lauren Budden listed as Group VP, CAO and Controller (previously VP, CAO and Controller) in SEC filings |
| Feb 11, 2022 | John W. Kapples listed as SVP and General Counsel (previously SVP, Secretary and GC) in SEC filings |
| Feb 4, 2022 | The company announced the departure of David A Lemoine from the board in an SEC filing |
| Feb 4, 2022 | Elizabeth H Weatherman became a director |
| Oct 15, 2021 | Luciana Borio became a director |
| Oct 20, 2020 | Wayne A.I. Frederick became a director |
| Jul 24, 2020 | Eric Benjamin listed as SVP, Innovation and Strategy (previously SVP, R&D, New Prod Dev. & Comm) in SEC filings |
| May 28, 2020 | Dan Manea became SVP, Chief HR Officer |
| Jul 31, 2019 | James Hollingshead became a director |
| Jun 14, 2019 | Michael P Spears listed as SVP, RA and Compliance (previously SVP, QA and RA) in SEC filings |
| Apr 29, 2019 | Lauren Budden became VP, CAO and Controller |
| Mar 18, 2019 | John W. Kapples became SVP, Secretary and GC |
| Feb 28, 2019 | Charles Alpuche listed as EVP & Chief Operating Officer (previously EVP & Chief Operations Officer) in SEC filings |
| Feb 28, 2019 | Bret Christensen listed as EVP and CCO (previously SVP and CCO) in SEC filings |
| Feb 18, 2019 | Wayde D. McMillan became EVP, CFO |
| Jan 25, 2019 | Corinne H Nevinny became a director |
| Jan 3, 2019 | Shacey Petrovic listed as President and CEO (previously President and COO) in SEC filings |
| Jan 3, 2019 | Shacey Petrovic first listed as a director in an SEC filing |
| Feb 15, 2018 | Charles Alpuche listed as EVP & Chief Operations Officer (previously EVP, Global Manufacturing) in SEC filings |
| Feb 15, 2018 | Aiman Abdel-Malek listed as EVP & Chief Technology Officer (previously SVP, Advanced Technology) in SEC filings |
| Feb 14, 2018 | Eric Benjamin became SVP, R&D, New Prod Dev. & Comm |
| Aug 10, 2017 | Michael R Minogue became a director |
| Aug 9, 2017 | James C Mullen became a director |
| May 26, 2017 | Bret Christensen became SVP and CCO |
| Feb 24, 2017 | Michael P Spears listed as SVP, QA and RA (previously SVP, Quality and Regulatory) in SEC filings |
| Feb 24, 2017 | Charles Alpuche listed as EVP, Global Manufacturing (previously SVP, Global Manufacturing) in SEC filings |
| Feb 10, 2017 | Shacey Petrovic listed as President and COO (previously President, Diabetes Products) in SEC filings |
| Dec 5, 2016 | Patrick J Sullivan listed as CEO and Chairman of the Board (previously President & CEO) in SEC filings |
- Prev
- 1
Not reported recently (13)
- Charles Alpuche · Last reported as Advisor in an SEC filing dated Mar 15, 2023
- Michael P Spears · Last reported as Advisor in an SEC filing dated Mar 13, 2023
- Bret Christensen · Last reported as EVP and CCO in an SEC filing dated Mar 1, 2023
- Sally Crawford · Last reported as a director in an SEC filing dated Jun 7, 2021
- John A. Fallon · Last reported as a director in an SEC filing dated May 25, 2021
- David Colleran · Last reported as SVP, Secretary and GC in an SEC filing dated Apr 4, 2019
- Aiman Abdel-Malek · Last reported as EVP & Chief Technology Officer in an SEC filing dated Apr 1, 2019
- Michael L Levitz · Last reported as SVP and CFO in an SEC filing dated Feb 28, 2019
- James C Mullen · Last reported as a director in an SEC filing dated May 18, 2018
- Patrick J Sullivan · Last reported as a director in an SEC filing dated Apr 2, 2018
- Bradley A Thomas · Last reported as EVP Human Resources in an SEC filing dated Apr 2, 2018
- Joseph S Zakrzewski · Last reported as a director in an SEC filing dated May 18, 2017
- Regina O Sommer · Last reported as a director in an SEC filing dated May 18, 2017
PODD Proposed Insider Sales (Form 144)
Latest: 2026-06-03What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.
How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.
10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.
"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.
Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.
| Filed | Filer | Role | Shares | Notice Value | Planned Sale | Broker | Plan | Link |
|---|---|---|---|---|---|---|---|---|
| 2026-06-03 | BORIO LUCIANA | Director | 418 | $59.9K | 2026-06-03 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2025-12-15 | Frederick Wayne A.I. | Director | 1,851 | $542.5K | 2025-12-15 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2025-11-26 | Manea Dan | Former Officer | 4,475 | $1.46M | 2025-11-26 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2025-11-24 | Manea Dan | Former Officer | 2,306 | $786.2K | 2025-11-24 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2025-09-16 | Manea Dan | Former Officer | 1,347 | $454.9K | 2025-09-16 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2025-09-08 | Cousin Laetitia | Officer | 797 | $278.0K | 2025-09-08 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2025-09-08 | Singh Prem | Officer | 687 | $238.7K | 2025-09-08 | Fidelity Brokerage Services LLC | — | EDGAR |
| 2025-08-21 | Benjamin Eric | Officer | 4,263 | $1.42M | 2025-08-21 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2025-08-07 | Singh Prem | Officer | 1,343 | $429.8K | 2025-08-07 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| 2025-06-13 | Singh Prem | Officer | 2,327 | $698.2K | 2025-06-13 | Fidelity Brokerage Services LLC | 10b5-1 | EDGAR |
| Filing Date | Accession | Link |
|---|---|---|
| 2026-05-26 | 0001145197-26-000132 | EDGAR |
| 2026-05-21 | 0001145197-26-000121 | EDGAR |
| 2026-05-06 | 0001145197-26-000100 | EDGAR |
| 2026-04-29 | 0001145197-26-000095 | EDGAR |
| 2026-03-12 | 0001145197-26-000081 | EDGAR |
| 2026-03-04 | 0001145197-26-000078 | EDGAR |
| 2026-02-18 | 0001145197-26-000026 | EDGAR |
| 2026-02-03 | 0001145197-26-000007 | EDGAR |
| 2025-12-19 | 0001628280-25-058252 | EDGAR |
| 2025-12-17 | 0001145197-25-000077 | EDGAR |
| Filing Date | Accession | Link |
|---|---|---|
| 2026-02-18 | 0001145197-26-000028 | EDGAR |
| 2025-02-21 | 0001145197-25-000007 | EDGAR |
| 2024-02-23 | 0001145197-24-000011 | EDGAR |
| 2023-02-24 | 0001145197-23-000020 | EDGAR |
| 2022-02-24 | 0001145197-22-000012 | EDGAR |
| 2021-02-24 | 0001145197-21-000009 | EDGAR |
| 2020-02-26 | 0001145197-20-000004 | EDGAR |
| 2019-02-26 | 0001145197-19-000003 | EDGAR |
| 2018-02-22 | 0001145197-18-000004 | EDGAR |
| 2017-02-28 | 0001145197-17-000005 | EDGAR |
| Filing Date | Accession | Link |
|---|---|---|
| 2026-05-06 | 0001145197-26-000102 | EDGAR |
| 2025-11-06 | 0001145197-25-000069 | EDGAR |
| 2025-08-07 | 0001145197-25-000038 | EDGAR |
| 2025-05-09 | 0001145197-25-000022 | EDGAR |
| 2024-11-08 | 0001145197-24-000045 | EDGAR |
| 2024-08-09 | 0001145197-24-000039 | EDGAR |
| 2024-05-10 | 0001145197-24-000022 | EDGAR |
| 2023-11-03 | 0001145197-23-000076 | EDGAR |
| 2023-08-09 | 0001145197-23-000059 | EDGAR |
| 2023-05-05 | 0001145197-23-000039 | EDGAR |
| # | ETF | Provider | Weight | $ Exposure | ETF AUM | As Of |
|---|---|---|---|---|---|---|
| 1 | VTI Vanguard Morningstar Total Stock Market ETF | Vanguard | 0.01% | $287.6M | — | 2026-09-30 |
| 2 | VOO Vanguard S&P 500 ETF | Vanguard | 0.01% | $237.6M | — | 2026-09-30 |
| 3 | RSP Invesco S&P 500 Equal Weight ETF | Invesco | 0.21% | $212.1M | — | 2026-10-24 |
| 4 | VB Vanguard Morningstar Small-Cap ETF | Vanguard | 0.11% | $203.7M | — | 2026-09-30 |
| 5 | IVV iShares Core S&P 500 ETF | iShares (BlackRock) | 0.02% | $136.5M | $873.6B | 2026-10-22 |
| 6 | SPY State Street® SPDR® S&P 500® ETF Trust | SPDR (State Street) | 0.02% | $126.2M | $810.5B | 2026-10-22 |
| 7 | VBK Vanguard Morningstar Small-Cap Growth ETF | Vanguard | 0.26% | $113.2M | — | 2026-09-30 |
| 8 | XLV State Street® Health Care Select Sector SPDR® ETF | SPDR (State Street) | 0.16% | $74.4M | $47.7B | 2026-10-22 |
| 9 | IWP iShares Russell Mid-Cap Growth ETF | iShares (BlackRock) | 0.31% | $57.9M | $18.7B | 2026-10-22 |
| 10 | IHI iShares U.S. Medical Devices ETF | iShares (BlackRock) | 1.35% | $48.5M | $3.6B | 2026-10-22 |
| 11 | IWR iShares Russell Mid-Cap ETF | iShares (BlackRock) | 0.08% | $43.0M | $57.0B | 2026-10-22 |
| 12 | IWF iShares Russell 1000 Growth ETF | iShares (BlackRock) | 0.03% | $38.6M | $122.3B | 2026-10-22 |
| 13 | SPYM State Street® SPDR® Portfolio S&P 500® ETF | SPDR (State Street) | 0.02% | $28.6M | $182.5B | 2026-10-22 |
| 14 | VHT Vanguard Health Care ETF | Vanguard | 0.13% | $27.6M | — | 2026-09-30 |
| 15 | DFAS Dimensional US Small Cap ETF | Dimensional | 0.07% | $25.5M | — | 2026-10-22 |
| 16 | IVW iShares S&P 500 Growth ETF | iShares (BlackRock) | 0.03% | $22.0M | $75.4B | 2026-10-22 |
| 17 | SCHG Schwab U.S. Large-Cap Growth ETF | Nport | 0.04% | $21.8M | — | 2026-05-31 |
| 18 | QGRO American Century U.S. Quality Growth ETF | Nport | 0.78% | $17.2M | — | 2026-05-31 |
| 19 | RSPH Invesco S&P 500 Equal Weight Health Care ETF | Invesco | 1.66% | $16.0M | — | 2026-10-24 |
| 20 | SPYG State Street® SPDR® Portfolio S&P 500® Growth ETF | SPDR (State Street) | 0.03% | $15.9M | $55.0B | 2026-10-22 |
| 21 | FMDE Fidelity Enhanced Mid Cap Core ETF | Nport | 0.21% | $15.7M | — | 2026-06-30 |
| 22 | DFAC Dimensional US Core Equity 2 ETF | Dimensional | 0.02% | $14.9M | — | 2026-10-22 |
| 23 | VONG Vanguard Russell 1000 Growth ETF | Vanguard | 0.03% | $14.7M | — | 2026-09-30 |
| 24 | ITOT iShares Core S&P Total U.S. Stock Market ETF | iShares (BlackRock) | 0.01% | $13.6M | $95.8B | 2026-10-22 |
| 25 | RPG Invesco S&P 500 Pure Growth ETF | Invesco | 0.67% | $11.6M | — | 2026-10-24 |
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.
Quarterly figures (12 quarters)
| Quarter | Period End | Revenue | Net Income | Diluted EPS | Op. Cash Flow |
|---|---|---|---|---|---|
| Q2 '26 | 2026-06-30 | $801.70M | $95.00M | $1.37 | $88.40M |
| Q1 '26 | 2026-03-31 | $761.70M | $91.10M | $1.30 | $113.80M |
| Q4 '25 | 2025-12-31 | $783.80M | $101.60M | $1.43 | $183.30M |
| Q3 '25 | 2025-09-30 | $706.30M | $87.60M | $1.24 | $125.70M |
| Q2 '25 | 2025-06-30 | $649.10M | $22.50M | $0.32 | $196.40M |
| Q1 '25 | 2025-03-31 | $569.00M | $35.40M | $0.50 | $63.90M |
| Q4 '24 | 2024-12-31 | $597.50M | $100.70M | $1.38 | $147.70M |
| Q3 '24 | 2024-09-30 | $543.90M | $77.50M | $1.08 | $108.30M |
| Q2 '24 | 2024-06-30 | $488.50M | $188.60M | $2.59 | $86.80M |
| Q1 '24 | 2024-03-31 | $441.70M | $51.50M | $0.73 | $87.60M |
| Q4 '23 | 2023-12-31 | $509.80M | $103.30M | $1.47 | $45.20M |
| Q3 '23 | 2023-09-30 | $432.70M | $51.90M | $0.74 | $56.00M |
Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.
- P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
- P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
- P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
- EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
- EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
- ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
- ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
- Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
- FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
- Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
- Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
- Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
- Multiples expanding while earnings are flat = sentiment-driven rally.
- Multiples compressing while earnings grow = value coming from fundamentals.
Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.
- Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
- SI % of Float — short interest / free float. The key crowding metric.
- Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
- Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
- Free Float — shares available for public trading (total shares minus insider / restricted).
- Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
- SI % of Float < 5% — typical, no particular signal.
- 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
- 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
- >30% — extreme; borrow is likely expensive and squeeze risk is material.
- Days to Cover > 5 combined with high SI% amplifies squeeze potential.
- Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
- A sudden drop in SI after a rally may indicate a squeeze in progress.
Short interest is reported mid-month and end-of-month; short volume is daily.